SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Escalating Middle East shipping and energy-infrastructure threats are driving crude-oil supply concerns and attention to USO. Traders are split between expecting further gains if disruptions persist and anticipating a pullback if diplomacy or additional supply eases the risks; many also worry that elevated oil prices could pressure equities and inflation.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras steep post-IPO slide and fresh lows are driving discussion, with traders pointing to continued lockup-related share supply and insider selling, as well as a TD Cowen price-target cut and concerns about growth and customer concentration. Bearish traders expect more pressure, while some bullish holders view the decline as an oversold buying opportunity and argue the companys AI-chip technology has long-term potential.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves debt-heavy expansion and rising financing costs are driving concern, amplified by HSBCs warning that slower AI demand could pressure growth. Traders are sharply divided: bears focus on refinancing risk, insider selling and the weak share price, while bulls point to contracted demand and recent analyst support.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a broad neocloud selloff as traders question whether AI infrastructure spending will earn adequate returns and how providers will finance expansion, with CoreWeaves debt concerns adding to fears of sector contagion. The community is split between viewing the recent rebound as an oversold buying opportunityciting Nebiuss comparatively stronger balance sheetand expecting further declines amid funding and cash-flow concerns.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A volatile tech-led rebound following an AI-stock selloff has QQQ traders debating whether dip-buying marks a recovery or a temporary bounce, with concerns about AI infrastructure spending and debt weighing against optimism ahead of major tech earnings. Rising oil prices add to macro unease, while many traders focus on whether the rebound can hold.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

UBSs downgrade of NuScale and cut to its price target have intensified selling, with traders focused on delayed project timelines, a lack of firm customer commitments, and cash-burn concerns. The community is divided between viewing the selloff as an opportunity and seeing it as evidence of execution risk, amid broader weakness in nuclear stocks.

Vicor Corp. engages in the design, development, manufacture, and marketing of modular power components. The firm provides complete power systems based upon a portfolio of patented technologies. Its products include AC-DC converters, power systems, and accessories. The company was founded by Patrizio Vinciarelli in 1981 and is headquartered in Andover, MA.

Vicor Corp.

Vicors Q3 report is driving attention: revenue beat expectations, while GAAP EPS fell short of some estimates and traders noted the lack of forward guidance. Reactions are mixed, with some focusing on strong growth and royalty revenue, while others question whether the results and outlook justify the stocks reaction.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Hot inflation readings and elevated yields have intensified concerns about Fed tightening, weighing on rate-sensitive small caps and keeping IWM near key support after a sharp pullback. Traders are split between expecting further downside and looking for an oversold bounce as yields ease and money rotates toward smaller companies.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs quarterly earnings beat expectations and the company announced a new share-repurchase authorization, but shares fell as traders focused on a narrowed full-year profit outlook without a higher midpoint. The reaction reflects a split between optimism over capital returns and stronger cash-flow expectations and concern that cautious guidance outweighed the earnings beat.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospace is drawing attention after a third-quarter earnings beat and an increase to its 2026 outlook. Traders largely praised the report but questioned the stocks decline, debating whether it reflects profit-taking or broader market weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Larimar (LRMR) Loses 22.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Larimar (LRMR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

5 Small Drug Stocks Poised to Benefit From a Biotech Recovery

INDV, IRWD, RLMD, LRMR and CRDL could offer significant upside as biotech sentiment improves, backed by catalysts and differentiated pipelines.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PR Newswire NEW YORK, July 23, 2026 NEW YORK, July 23, 2026...

Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy

Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PR Newswire NEW YORK, July 9, 2026 NEW YORK, July 9, 2026...

LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000

Equity

The shares were acquired in multiple transactions at prices ranging from $3.33 to $3.35 per share. 


LRMR Shares Hold Steady As Wall Street Optimism Offsets Drug Safety Concerns

H.C. Wainwright initiated coverage of Larimar with a ‘Buy’ rating and a $10 price target on Thursday.


INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PR Newswire NEW YORK, July 1, 2026 NEW YORK, July 1, 2026...

Larimar Stock Slides 15% Despite FDA Backing Rolling Submission For Rare Disease Drug

Larimar Therapeutics Inc (LRMR) submits first module of Biologics License Application for investigational treatment for Friedreich's ataxia, with FDA support and positive long-term data showing durable safety profile and clinical improvements compared to natural history data.read more...

Larimar's Rare Disease Push Just Hit A Key Inflection Point — What Investors Need To Know

Larimar submitted the module of a rolling biologics license application to the U.S. Food and Drug Administration for the accelerated approval of nomlabofusp for Friedreich’s ataxia.

Larimar Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing treatments for patients suffering from complex rare diseases using a novel cell penetrating peptide technology platform. It also engages in the research, development, and commercialization of novel therapeutics for mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Bullish Sentiment

<ul class="summary-bullets"><li>Following the transaction, Thomas E. Hamilton directly owns 714,798 shares.</li><li>Earlier this month, H.C. Wainwright initiated coverage of Larimar with a ‘Buy’ rating and a $10 price target.&nbsp;</li><li>H.C. Wainwright forecasts a commercial launch of Larimar’s nomlabofusp in 2027.</li></ul>Shares of Larimar Therapeutics, Inc. (LRMR) jumped 3% after hours on Wednesday after its director, Thomas E. Hamilton, purchased 50,000 shares of the company’s common stock.The shares were acquired in multiple transactions at prices ranging from $3.33 to $3.35 per share, for a weighted average price of $3.3378. The total value of the purchase was approximately $166,890.Following the transaction, Hamilton directly owns 714,798 shares. He also holds 159,433 shares indirectly through Post Edison, LLC.<h2 class="st-heading-2">Larimar Pipeline Development Efforts</h2>Larimar Therapeutics is a clinical-stage biotech company developing nomlabofusp, a potential treatment for Friedreich’s ataxia (FA). The company recently submitted the first module of a rolling Biologics License Application (BLA) to the FDA for accelerated approval.The remaining modules of the application are slated to be filed in the second half of the year.Earlier this month, H.C. Wainwright initiated coverage of Larimar with a ‘Buy’ rating and a $10 price target, highlighting the firm’s regulatory progress for nomlabofusp as a key driver of value.The analyst expects Larimar to submit its full Biologics License Application (BLA) for nomlabofusp later this year. The note stated the filing is likely to receive priority review from the FDA, which could shorten the standard review timeline and speed up a potential approval decision.H.C. Wainwright forecasts a commercial launch of nomlabofusp in 2027, with first-year U.S. sales of $47.9 million. The firm projects peak annual sales could exceed $1.1 billion by 2040, reflecting strong commercial potential in the rare disease space.<h2 class="st-heading-2">How Did LRMR Retail Traders React?</h2>On Stocktwits, retail sentiment around LRMR stock stayed within the ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.A Stocktwits user highlighted that the director has “lot of shares” and has been putting in “real money” into the stock.<stembedurl>https://www.stocktwits.com/longterminvs/message/658598616</stembedurl>Another user focused on the company’s potential with regard to its pipeline and opined that if nomlabofusp is approved in Friedreich’s ataxia, it could open the “floodgates for reevaluation to the multibillion range.”<stembedurl>https://www.stocktwits.com/i_am_the_walrus_67/message/658548203</stembedurl><a href="https://stocktwits.com/symbol/LRMR">LRMR stock</a> has fallen by about 5% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/alhc-stock-clocks-worst-day-in-over-2-years-on-whistleblower-financial-manipulation-allegation/cZmn2r1R7VJ">ALHC Stock Clocks Worst Day In Over 2 Years On Whistleblower Financial Manipulation Allegation</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

The shares were acquired in multiple transactions at prices ranging from $3.33 to $3.35 per share. 

Vanguard Total Stock Market ETF

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Current Price	$2.12
Prev Close	$1.99
Open	$1.99
Dividend Yield	N/A
50-Day Moving Average	$3.54
Beta	1.60
Avg. Volume	1.38M
PE Ratio	-1.07

52-Week High	$6.42
52-Week Low	$1.92
Market Capitalization	$206.21M
EPS (Annual)	-$2.26
Price to Book	1.74
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

LRMR Fundamentals